Recent trials have shown: Up to 20% body weight reduction with weekly GLP-1 agonists (Wilding et al., NEJM) Improvements in HbA1c, fasting glucose, and cardiovascular outcomes (Marso et al., NEJM) This drug class is now widely used for: Obesity (with or without diabetes) Type 2 diabetes PCOS-related insulin resistance Metabolic syndrome Common Side Effects and Patient Concerns Despite their benefits, GLP-1 agonists are not without risks or drawbacks
Our team provides the nutritional guidance and lifestyle support you need to build healthy habits that last a lifetime
How it works Peptide Therapy: Stimulates specific pathways (e.g., growth-hormone signalling, tissue repair, metabolic activity)
A fever is the bodys natural response to infection, indicating that the immune system is fighting off bacteria
The TE literature and bariatric meta-analyses tell us it is the speed and magnitude that predict shedding risk, not a single cut-off
These treatments arent a onesizefitsall solution, but certain people tend to see the most significant benefits
